Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
D000328:Adult; D000368:Aged; D001761:Bleomycin / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008130:Lomustine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000009:adverse effects*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000009:adverse effects*
D009607:Nitrosourea Compounds; D001761:Bleomycin; D008130:Lomustine; D013713:Teniposide; D011034:Podophyllotoxin